Table 1 Baseline characteristics
Variables | Potentially avoidable | |||
|---|---|---|---|---|
All, N = 137, (%) | Yes, N = 51 (%) | No, N = 86 (%) | p value | |
Age group (year) | 0.969 | |||
-60 | 41 (29.9) | 15 (36.6) | 26 (63.4) | |
61–70 | 30 (21.9) | 11 (36.7) | 19 (63.3) | |
71–80 | 42 (30.7) | 16 (35.7) | 26 (64.3) | |
81+ | 24 (17.5) | 10 (41.7) | 14 (58.3) | |
Sex | 0.409 | |||
Male | 88 (64.2) | 35 (39.8) | 53 (60.2) | |
Female | 49 (35.8) | 16 (32.7) | 33 (67.3) | |
Cancer type | 0.021 | |||
Lung cancer | 41 (29.9) | 20 (48.8) | 21 (51.2) | |
Hematologic malignancy | 24 (17.5) | 2 (8.3) | 22 (91.7) | |
Stomach cancer | 23 (16.8) | 9 (39.1) | 14 (60.9) | |
Lymphoma | 20 (14.6) | 6 (30.0) | 14 (70.0) | |
Oesophageal cancer | 5 (3.6) | 2 (40.0) | 3 (60.0) | |
Pancreas-biliary cancer | 5 (3.6) | 2 (40.0) | 3 (60.0) | |
Breast cancer | 5 (3.6) | 4 (80.0) | 1 (20.0) | |
Colorectal cancer | 4 (2.9) | 3 (75.0) | 1 (25.0) | |
Other | 10 (7.3) | 3 (30.0) | 7 (70.0) | |
Reasons of hospitalization | 0.207 | |||
Cancer symptom | 70 (51.1) | 31 (44.3) | 39 (55.7) | |
Planned | 51 (37.2) | 17 (33.3) | 34 (66.7) | |
Treatment complication | 9 (6.6) | 2 (22.2) | 7 (77.8) | |
Non-cancer medical condition | 7 (5.1) | 1 (14.3) | 6 (85.7) | |
Clinical setting at CPR | < 0.001a | |||
Curative/adjuvant | 24 (17.5) | 3 (12.5) | 21 (87.5) | |
No prior chemotherapy | 30 (21.9) | 8 (26.7) | 22 (73.3) | |
1st palliative | 29 (21.2) | 10 (34.5) | 19 (65.6) | |
2nd palliative | 25 (18.2) | 10 (40.0) | 15 (60.0) | |
3rd palliative or more | 29 (21.2) | 20 (69.0) | 9 (31.0) | |
Interval from last chemotherapy (median, 25–75%, days) | 31.0 (8.5–56.0) | 37.0 (13.0–63.0) | 29.5 (8.0–52.0) | |